Drawing for GENEOPTIMIZER

USPTO serial 78274936

GENEOPTIMIZER

Reviewed by CopyMark Law Group

Reg. 3111123Status 800Renewal
Filing date
Status date
Registration date
Jul 4, 2006
Examiner
CARRUTHERS, SUE
Law office
GENERIC WEB UPDATE

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with GENEOPTIMIZER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,700

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenya L. Williams

Kenya L. Williams Thermo Fisher Scientific5823 Newton DriveCarlsbad, CA 92008UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Bacteria for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biological and diagnostic materials and preparations for research use, namely, proteins, DNA, RNA and modifications thereof; and enzymes and enzyme preparations for use in the field of food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds ]SECTION 8 - CANCELLED—
005[ Medicines for human medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; bacteriological preparations for medical and veterinary purposes, for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis, as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones, and enzymes for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; germicides for medical and laboratory equipment, institutional use, and domestic uses; vermicides for medical and laboratory equipment, institutional use, domestic use, and residential uses; fungicides for medical and laboratory equipment, institutional use, and domestic uses; biological and diagnostic materials and preparations for clinical and medical laboratory use, namely, proteins, DNA, RNA and modifications thereof ]SECTION 8 - CANCELLED—
009[ Computer terminals; ] computer programs for use as tools in the field of biotechnology and molecular biology; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations, diagnostic preparations; [ computer operating programs; computer peripheral devices; computer keyboards; blank magnetic data carriers; blank optical disks; data processors; computer memories; blank floppy disks; hard drives for computers; printers for use with computers; computer interfaces; laptop computers; data processing equipment, namely, readers and scanners; computer mouse; semiconductors; computer modems; computer monitors; computer hardware; notebook computers; ] automatic machines for the synthesis of deoxyribonucleic acids; and robotic machines for laboratory purposesACTIVE—
042Computer services, namely, updating of computer software for others, consulting in the field of biotechnology, designing computer software for others, maintenance of computer software for others, leasing of computer software; computer programming for others, leasing of computers, and reconstruction of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; laboratory services for others in the fields of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering and machine engineering; consultation pertaining to pharmacology; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, and machine engineering; and quality control for othersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 4, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 10, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 10, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 10, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 10, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 14, 2016NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jun 14, 2016RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jun 14, 201689AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jun 13, 2016E89RTEAS SECTION 8 & 9 RECEIVED—
Mar 2, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 4, 2015REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jul 23, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 10, 2012NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 10, 2012C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 10, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 23, 2012815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Jul 23, 2012E815TEAS SECTION 8 & 15 RECEIVED—
Jul 23, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 21, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 2, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 1, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 20, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 4, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 11, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 22, 2006NPUBNOTICE OF PUBLICATION—
Feb 2, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 23, 2005ALIEASSIGNED TO LIE—
Sep 19, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 19, 2005GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 14, 2005ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 12, 2005PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 23, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 19, 2005ALIEASSIGNED TO LIE—
Aug 15, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 15, 2005TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2005GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 8, 2005CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 6, 2005ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 17, 2005CWBPWITHDRAWN BEFORE PUBLICATION—
Sep 17, 2004ALIEASSIGNED TO LIE—
Sep 7, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 3, 2004ALIEASSIGNED TO LIE—
Jun 3, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 5, 20041.BDSec. 1(B) CLAIM DELETED—
May 5, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 5, 2004MAILPAPER RECEIVED—
Jan 6, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance